Profound Medical and Telix sign co-education agreement
Profound Medical and Telix Pharmaceuticals announced a co-education agreement to train physicians and prostate cancer centers on PSMA-PET molecular imaging and MRI-guided TULSA-PRO.
Profound Medical and Telix Pharmaceuticals announced a co-education agreement to train physicians and prostate cancer centers on PSMA-PET molecular imaging and MRI-guided TULSA-PRO.